Cita APA

Williams, P. D., Zlokovic, B. V., Griffin, J. H., Pryor, K. E., & Davis, T. P. (2012). Preclinical Safety and Pharmacokinetic Profile of 3K3A-APC, a Novel, Modified Activated Protein C for Ischemic Stroke.

Citación estilo Chicago

Williams, Patricia D., Berislav V. Zlokovic, John H. Griffin, Kent E. Pryor, y Thomas P. Davis. Preclinical Safety and Pharmacokinetic Profile of 3K3A-APC, a Novel, Modified Activated Protein C for Ischemic Stroke. 2012.

Cita MLA

Williams, Patricia D., et al. Preclinical Safety and Pharmacokinetic Profile of 3K3A-APC, a Novel, Modified Activated Protein C for Ischemic Stroke. 2012.